Aurealis Therapeutics
Manufacturing · Finland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Microkatu 1, Kuopio, Northern Savo, 7021...Phone Number
+358 458433550Website
www.aurealistherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Aurealis Therapeutics
Aurealis Therapeutics specializes in multi-target cell and gene therapies aimed at addressing unmet medical needs, particularly in chronic wounds, cancer, and inflammatory diseases. Their innovative platform is designed to treat complex multi-factorial diseases, including diabetic foot ulcers and various cancers. The company is committed to advancing scientific research to improve patient outcomes through effective therapies. Their target clients include patients suffering from chronic wounds and life-threatening cancers.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aurealis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Aurealis Therapeutics recently announced quarterly report
Product Launch: Get notified when Aurealis Therapeutics launches new products
Check out if Aurealis Therapeutics is spiking on competitors!
Click to see if Aurealis Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aurealis Therapeutics
Funding: Get notified immidiatlly once Aurealis Therapeutics has new funding data
Aurealis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Aurealis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Aurealis Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Aurealis Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aurealis Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aurealis Therapeutics.
Aurealis Therapeutics Tech Stack
A closer look at the technologies used by Aurealis Therapeutics
Aurealis Therapeutics News & Media
Aurealis Therapeutics raises CHF 8M to complete Phase-2 studies in Chronic Wounds and accelerate Oncology program
Funds will be used to complete Phase 2 RCTs with AUP-16 for Chronic Wounds, and accelerate the development of AUP-55 for ovarian, peritoneal and bladder cancer. ZUG, SWITZERLAND, November 13, 2024 /EINPresswire.com/ -- Aurealis Therapeutics, a synthetic …Aurealis Therapeutics completes 50% patient recruitment for DIAMEND Phase-2 study in Diabetic Foot Ulcers
Half of the patients expected to participate DIAMEND Phase-2 study with AUP-16 in Diabetic Foot Ulcers (DFUs) have now been recruited and randomized. ZUG, SWITZERLAND, March 11, 2024 /EINPresswire.com/ -- Aurealis Therapeutics, a Swiss-Nordic clinical- …Aurealis Therapeutics’ lead candidate AUP-16 for chronic wounds receives PRIME status from EMA
Aurealis Therapeutics receives PRIME status from EMA for Enhanced Regulatory Support and Accelerated Assessment of AUP-16 in Non-healing Diabetic Foot Ulcers ZUG, SWITZERLAND, February 27, 2024 /EINPresswire.com/ -- • Priority medicines (PRIME) is a …Aurealis Therapeutics Announces First Patient Dosed in DIAMEND Phase 2 Diabetic Foot Ulcer Clinical Trial of AUP-16
BASEL, BASEL-STADT, SWITZERLAND, August 8, 2023 /EINPresswire.com/ -- Aurealis Therapeutics, a Swiss-Finnish clinical-stage synthetic biology company developing bacteria-based multi-target cell and gene therapies for chronic wounds and cancer, announced …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aurealis Therapeutics
Sign Up For FreeTo access detailed company insights
Aurealis Therapeutics specializes in multi-target cell and gene therapies aimed at addressing unmet medical needs, particularly in chronic wounds, cancer, and inflammatory diseases. Their innovative platform is designed to treat complex multi-factorial diseases, including diabetic foot ulcers and various cancers. The company is committed to advanci... Read More
